A new market study, titled “Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size, Status and Forecast 2025”, has been featured on WiseGuyReports.
This report studies the global Hematopoietic Stem Cells Transplantation (HSCT) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Hematopoietic Stem Cells Transplantation (HSCT) market by companies, region, type and end-use industry.
Hematopoietic stem cell transplants (HSCT) present to a valid treatment for several congenital and other hematopoietic system disorders, post chemotherapy, and immune sensitive diseases. HSCT is also preferred for replacement of cellular components and deficient cells. The indications for HSCT thus are wide; the most frequent indication as per reported by Worldwide Network for Blood and Marrow Transplantation Group (WNBT) (2013) is lymphoproliferative disorder (53.2% of all HSCT), 12% of whom received allogeneic and the rest received autologous transplant. Plasma cell disorders are the most frequent indication in this group. A multitude of literature published by researchers and organizations demonstrate that autologous transplant own a greater edge against allogeneic HSCT.
Over 30 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach it may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.
Hematopoietic stem cells are unable to proliferate and differentiate in-vitro. Researchers have yet to evolve an accurate method to differentiate stem cells from other cells derived from blood or bone marrow. Once such technical barriers are overcome, the avenues for realizing the full potential of HSCT. The type of transplant a person receives depends on several different factors, including the type and course of the disease, availability of suitable donors, and the patient’s overall health. There are three different sources of hematopoietic stem cells such as bone marrow, peripheral blood stem cells, and umbilical cord blood. The stem cell source used for a given transplant depends upon the underlying disease, the type of transplant (allogeneic or autologous), and size of the patient.
In 2017, the global Hematopoietic Stem Cells Transplantation (HSCT) market is expected to reach xx million US$ by the end of 2025, with a healthy CAGR during 2018-2025.
This report focuses on the global top players, covered
Kite Pharma
Thermo Fisher Scientific
CellGenix Technologie Transfer
Cesca Therapeutics
R&D Systems
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Request Sample Report at https://www.wiseguyreports.com/sample-request/3329373-global-hematopoietic-stem-cells-transplantation-hsct-market-size
Market segment by Type, the product can be split into
Autologous Transplant
Allogenic Transplant
Market segment by Application, split into
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
Others
The study objectives of this report are:
To study and forecast the market size of Hematopoietic Stem Cells Transplantation (HSCT) in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Hematopoietic Stem Cells Transplantation (HSCT) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Hematopoietic Stem Cells Transplantation (HSCT) Manufacturers
Hematopoietic Stem Cells Transplantation (HSCT) Distributors/Traders/Wholesalers
Hematopoietic Stem Cells Transplantation (HSCT) Subcomponent Manufacturers
Industry Association
Downstream Vendors
Table of Contents
1 Industry Overview of Hematopoietic Stem Cells Transplantation (HSCT)
2 Global Hematopoietic Stem Cells Transplantation (HSCT) Competition Analysis by Players
3 Company (Top Players) Profiles
4 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Type and Application (2013-2018)
5 United States Hematopoietic Stem Cells Transplantation (HSCT) Development Status and Outlook
6 Europe Hematopoietic Stem Cells Transplantation (HSCT) Development Status and Outlook
7 China Hematopoietic Stem Cells Transplantation (HSCT) Development Status and Outlook
8 Japan Hematopoietic Stem Cells Transplantation (HSCT) Development Status and Outlook
9 Southeast Asia Hematopoietic Stem Cells Transplantation (HSCT) Development Status and Outlook
10 India Hematopoietic Stem Cells Transplantation (HSCT) Development Status and Outlook
11 Market Forecast by Regions, Type and Application (2018-2025)
12 Hematopoietic Stem Cells Transplantation (HSCT) Market Dynamics
13 Market Effect Factors Analysis
14 Research Finding/Conclusion
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Your information will never be shared with any third party.